{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:33:51Z","timestamp":1757543631285,"version":"3.40.5"},"reference-count":12,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2024,8,2]]},"DOI":"10.1080\/14740338.2023.2273334","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T02:38:41Z","timestamp":1697683121000},"page":"1017-1020","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Ondansetron induced blindness: a pharmacovigilance database study"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1512-1265","authenticated-orcid":false,"given":"R.","family":"Barus","sequence":"first","affiliation":[{"name":"Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital, Toulouse, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Potey","sequence":"additional","affiliation":[{"name":"Pharmacology department, Lille University Hospital, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gautier","sequence":"additional","affiliation":[{"name":"Pharmacology department, Lille University Hospital, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2594-0993","authenticated-orcid":false,"given":"G.","family":"Wabont","sequence":"additional","affiliation":[{"name":"Pharmacology department, Lille University Hospital, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"key":"e_1_3_6_3_1","unstructured":"Zofran Injection (ondansetron hydrochloride) dose indications adverse effects interactions\u2026 from PDR.Net. https:\/\/www.pdr.net\/drug-summary\/Zofran-Injection-ondansetron-hydrochloride-243 (consult\u00e9 le 8 f\u00e9vrier 2022)."},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/009286150804200501"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04037.x"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.05.008"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2017.08.006"},{"key":"e_1_3_6_8_1","unstructured":"European Medicines Agency. Screening for adverse reactions in EudraVigilance. d\u00e9cembre 2016. https:\/\/www.ema.europa.eu\/en\/documents\/other\/screening-adverse-reactions-eudravigilance_en.pdf (consult\u00e9 le 6 septembre 2022)."},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2005.04348.x"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-1644-9"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(01)01998-9"},{"key":"e_1_3_6_13_1","article-title":"Serotonin receptor subtype mRNA expression in human ocular tissues, determined by RT-PCR","volume":"12","author":"Sharif NA","year":"2006","unstructured":"Sharif NA, Senchyna EM. Serotonin receptor subtype mRNA expression in human ocular tissues, determined by RT-PCR. Mol Vis. sept 2006;12:1040\u20111047.","journal-title":"Mol Vis"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.01.015"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00881.x"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2273334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T18:29:38Z","timestamp":1727202578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2273334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,2]]}},"alternative-id":["10.1080\/14740338.2023.2273334"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2273334","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"type":"print","value":"1474-0338"},{"type":"electronic","value":"1744-764X"}],"subject":[],"published":{"date-parts":[[2023,10,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}